We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sysmex Corporation and ThinkCyte, Inc. announced the signing of joint development and investment agreements during May 2021 for the commercialization of an AI-based cell analysis technology.